Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2020
Reporting Period: First quarter ended March 31, 2020 (results to be discussed in upcoming call)
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of an upcoming earnings announcement rather than a disclosure of financial data.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The document solely announces the scheduling of a conference call to discuss the first quarter results.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company will host a conference call on May 14, 2020, at 4:30 PM Eastern Time.
Purpose: To discuss financial results for the first quarter ended March 31, 2020.
Exhibits: A press release dated May 6, 2020, is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the date and time of the conference call (May 14, 2020, 4:30 PM ET).
- Review the attached press release (Exhibit 99.1) for any preliminary highlights.
- Monitor the Company's website or investor relations portal for the earnings presentation and financial statements following the call.
- Confirm the trading symbol (INMB) on The NASDAQ Stock Market LLC.